Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 22;11(3):e041541.
doi: 10.1136/bmjopen-2020-041541.

Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial

Aisling Croke  1 , Frank Moriarty  2   3 , Fiona Boland  2   4 , Laura McCullagh  5   6 , Karen Cardwell  2 , Susan M Smith  2 , Barbara Clyne  2
Affiliations

Integrating clinical pharmacists within general practice: protocol for a pilot cluster randomised controlled trial

Aisling Croke et al. BMJ Open. .

Abstract

Introduction: Managing patients with multiple conditions (multimorbidity) is a major challenge for healthcare systems internationally, particularly in older patients. Multimorbidity and subsequent polypharmacy increase treatment burden and the risk of potentially inappropriate prescribing, and both are complex to manage in primary care. Limited evidence suggests integration of pharmacists into general practice teams could improve medication management for patients with multimorbidity and polypharmacy. Building on findings from a non-randomised, uncontrolled General Practice Pharmacist (GPP) feasibility study conducted in Irish primary care, the aim of this study is to conduct a pilot cluster randomised controlled trial (cRCT) of the GPP study, to assess feasibility, intervention impact, costs and appropriateness of continuing to a definitive cRCT.

Methods and analysis: This pilot cRCT will involve 8 general practitioner (GP) practices and 120 patients. Practices will identify and recruit patients aged ≥65 years, who are taking ≥10 regular medications. Practices will be allocated to intervention or control after baseline data collection. Intervention practices will have a pharmacist integrated within their service, working with GPs, patients and practice staff to optimise prescribing and other medication-related activities. Control practices will provide standard GP care. The primary feasibility outcomes will include recruitment rate, uptake of medication reviews and study retention. For the primary clinical outcome, the number of potentially inappropriate prescribing incidences per patient will be collected. Secondary outcomes will include medication-related outcomes, patient-reported outcome measures, and data pertaining to the role and impact of the pharmacist on prescribing. In addition, economic and process evaluations will be conducted.

Ethics and dissemination: This trial has been approved by the Irish College of General Practitioners Research Ethics Committee and will be performed in accordance with the Declaration of Helsinki. The results will be reported in peer-reviewed journals and be presented at national and international conferences.

Trial registration number: ISRCTN Registry (https://doi.org/10.1186/ISRCTN18752158).

Keywords: organisation of health services; primary care; protocols & guidelines.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow of practices through the GPP Medicines Optimisation Programme pilot cRCT. cRCT, cluster randomised controlled trial; GPP, General Practice Pharmacist.
Figure 2
Figure 2
Flow chart for GPP Medicines Optimisation Programme intervention. GP, general practitioner; GPP, General Practice Pharmacist.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Nguyen H, Manolova G, Daskalopoulou C, et al. . Prevalence of multimorbidity in community settings: a systematic review and meta-analysis of observational studies. J Comorb 2019;9:2235042X19870934-2235042X 10.1177/2235042X19870934 - DOI - PMC - PubMed
    1. Moriarty F, Hardy C, Bennett K, et al. . Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 2015;5:e008656. 10.1136/bmjopen-2015-008656 - DOI - PMC - PubMed
    1. Hughes LD, McMurdo MET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing 2013;42:62–9. 10.1093/ageing/afs100 - DOI - PubMed
    1. Hedna K, Hakkarainen KM, Gyllensten H, et al. . Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol 2015;71:1525–33. 10.1007/s00228-015-1950-8 - DOI - PMC - PubMed
    1. Cooper JA, Cadogan CA, Patterson SM, et al. . Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open 2015;5:e009235. 10.1136/bmjopen-2015-009235 - DOI - PMC - PubMed

Publication types

LinkOut - more resources